AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glycilarc Trio 2/0.3mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Wynclark Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Glycilarc Trio 2/0.3mg Tablet ER

Diabetic patients with type 2 mellitus may find relief with the extended-release formulation of Trioglyc 2/0.3mg tablets, a dual-action antidiabetic medication. This combined therapy helps regulate blood glucose. Administer this medication orally with food, consistently at the same time daily for optimal effectiveness. Dosage adjustments, determined by your physician based on your blood sugar readings, may be necessary. Continuous use is crucial; discontinuation without medical consultation risks elevated blood glucose, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Commonly reported is hypoglycemia (low blood sugar). Learn to recognize its symptoms (sweating, dizziness, headache, tremors) and implement appropriate countermeasures, such as consuming fast-acting carbohydrates like glucose tablets or juice. Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential adverse effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions warrant discussion with your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are essential to manage the therapy effectively.

Uses of Glycilarc Trio 2/0.3mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glycilarc Trio 2/0.3mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glycilarc Trio 2/0.3mg Extended-Release tablet whole; do not damage it in any way. Administer on an empty stomach.

Common Side effects of Glycilarc Trio 2/0.3mg Tablet ER:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glycilarc Trio 2/0.3mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycilarc Trio 2/0.3mg Tablet ER. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.

How Glycilarc Trio 2/0.3mg Tablet ER works:

Extended-release Glycilarc Trio tablets (2/0.3mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycilarc Trio 2/0.3mg Extended-Release Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glycilarc Trio 2/0.3mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glycilarc Trio 2/0.3mg tablet is likely unsafe for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Employing Glycilarc Trio 2/0.3mg Extended-Release tablets in individuals with kidney impairment is likely inadvisable and should be prevented. A physician's consultation is necessary. Furthermore, Glycilarc Trio 2/0.3mg Extended-Release tablets are not suggested for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glycilarc Trio 2/0.3mg Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glycilarc Trio 2/0.3mg Tablet ER :

Should you forget a Glycilarc Trio 2/0.3mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycilarc Trio 2/0.3mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glycilarc Trio 2/0.3mg Tablet ER

Glycilarc Trio 2/0.3mg Extended-Release tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release, metformin reduces liver glucose production and enhances insulin sensitivity, and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Glycilarc Trio 2/0.3mg Tablet ER may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste, gas, stomach pain, headache, rash, and respiratory infections.
Glycilarc Trio 2/0.3mg Tablet ER is contraindicated in patients with allergies to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Glycilarc Trio 2/0.3mg Tablet ER with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glycilarc Trio 2/0.3mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly sealed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Glycilarc Trio 2/0.3mg Ta...
143
MRP 166
13% off